Bill Text: FL H0873 | 2010 | Regular Session | Introduced


Bill Title: Controlled Substances

Spectrum: Partisan Bill (Republican 1-0)

Status: (Failed) 2010-04-30 - Died in Committee on Health Care Regulation Policy (HFPC) [H0873 Detail]

Download: Florida-2010-H0873-Introduced.html
HB 873
1
A bill to be entitled
2An act relating to controlled substances; amending s.
3893.03, F.S.; revising the list of controlled substances
4in Schedules I, II, III, IV, and V; providing that the
5salts, isomers, or salts of isomers are included within
6certain substances listed in Schedule III; providing an
7effective date.
8
9Be It Enacted by the Legislature of the State of Florida:
10
11 Section 1. Paragraph (c) of subsection (1), paragraphs (a)
12and (b) of subsection (2), paragraph (a) of subsection (3),
13subsection (4), and paragraph (b) of subsection (5) of section
14893.03, Florida Statutes, are amended to read:
15 893.03 Standards and schedules.-The substances enumerated
16in this section are controlled by this chapter. The controlled
17substances listed or to be listed in Schedules I, II, III, IV,
18and V are included by whatever official, common, usual,
19chemical, or trade name designated. The provisions of this
20section shall not be construed to include within any of the
21schedules contained in this section any excluded drugs listed
22within the purview of 21 C.F.R. s. 1308.22, styled "Excluded
23Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical
24Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted
25Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt
26Anabolic Steroid Products."
27 (1) SCHEDULE I.-A substance in Schedule I has a high
28potential for abuse and has no currently accepted medical use in
29treatment in the United States and in its use under medical
30supervision does not meet accepted safety standards. The
31following substances are controlled in Schedule I:
32 (c) Unless specifically excepted or unless listed in
33another schedule, any material, compound, mixture, or
34preparation which contains any quantity of the following
35hallucinogenic substances or which contains any of their salts,
36isomers, and salts of isomers, whenever the existence of such
37salts, isomers, and salts of isomers is possible within the
38specific chemical designation:
39 1. Alpha-ethyltryptamine.
40 2. 2-Amino-4-methyl-5-phenyl-2-oxazoline (4-
41methylaminorex).
42 3. 2-Amino-5-phenyl-2-oxazoline (Aminorex).
43 4. 4-Bromo-2,5-dimethoxyamphetamine.
44 5. 4-Bromo-2, 5-dimethoxyphenethylamine.
45 6. Bufotenine.
46 7. Cannabis.
47 8. Cathinone.
48 9. Diethyltryptamine.
49 10. 2,5-Dimethoxyamphetamine.
50 11. 2,5-Dimethoxy-4-ethylamphetamine (DOET).
51 12. Dimethyltryptamine.
52 13. N-Ethyl-1-phenylcyclohexylamine (PCE) (Ethylamine
53analog of phencyclidine).
54 14. N-Ethyl-3-piperidyl benzilate.
55 15. N-ethylamphetamine.
56 16. Fenethylline.
57 17. N-Hydroxy-3,4-methylenedioxyamphetamine.
58 18. Ibogaine.
59 19. Lysergic acid diethylamide (LSD).
60 20. Mescaline.
61 21. Methcathinone.
62 22. 5-Methoxy-3,4-methylenedioxyamphetamine.
63 23. 4-methoxyamphetamine.
64 24. 4-methoxymethamphetamine.
65 25. 4-Methyl-2,5-dimethoxyamphetamine.
66 26. 3,4-Methylenedioxy-N-ethylamphetamine.
67 27. 3,4-Methylenedioxyamphetamine.
68 28. N-Methyl-3-piperidyl benzilate.
69 29. N,N-dimethylamphetamine.
70 30. Parahexyl.
71 31. Peyote.
72 32. N-(1-Phenylcyclohexyl)-pyrrolidine (PCPY) (Pyrrolidine
73analog of phencyclidine).
74 33. Psilocybin.
75 34. Psilocyn.
76 35. Salvia divinorum, except for any drug product approved
77by the United States Food and Drug Administration which contains
78Salvia divinorum or its isomers, esters, ethers, salts, and
79salts of isomers, esters, and ethers, whenever the existence of
80such isomers, esters, ethers, and salts is possible within the
81specific chemical designation.
82 36. Salvinorin A, except for any drug product approved by
83the United States Food and Drug Administration which contains
84Salvinorin A or its isomers, esters, ethers, salts, and salts of
85isomers, esters, and ethers, whenever the existence of such
86isomers, esters, ethers, and salts is possible within the
87specific chemical designation.
88 37. Tetrahydrocannabinols.
89 38. 1-[1-(2-Thienyl)-cyclohexyl]-piperidine (TCP)
90(Thiophene analog of phencyclidine).
91 39. 3,4,5-Trimethoxyamphetamine.
92 40. Alpha-methyltryptamine.
93 41. 1-(1-Phenylcyclohexyl) pyrrolidine.
94 42. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine.
95 43. 5-Methoxy-N, N-diisopropyltryptamine.
96 44. N-Benzylpiperazine.
97 (2) SCHEDULE II.-A substance in Schedule II has a high
98potential for abuse and has a currently accepted but severely
99restricted medical use in treatment in the United States, and
100abuse of the substance may lead to severe psychological or
101physical dependence. The following substances are controlled in
102Schedule II:
103 (a) Unless specifically excepted or unless listed in
104another schedule, any of the following substances, whether
105produced directly or indirectly by extraction from substances of
106vegetable origin or independently by means of chemical
107synthesis:
108 1. Opium and any salt, compound, derivative, or
109preparation of opium, except nalmefene or isoquinoline alkaloids
110of opium, including, but not limited to the following:
111 a. Raw opium.
112 b. Opium extracts.
113 c. Opium fluid extracts.
114 d. Powdered opium.
115 e. Granulated opium.
116 f. Tincture of opium.
117 g. Codeine.
118 h. Ethylmorphine.
119 i. Etorphine hydrochloride.
120 j. Hydrocodone.
121 k. Hydromorphone.
122 l. Levo-alphacetylmethadol (also known as levo-alpha-
123acetylmethadol, levomethadyl acetate, or LAAM).
124 m. Metopon (methyldihydromorphinone).
125 n. Morphine.
126 o. Oxycodone.
127 p. Oxymorphone.
128 q. Thebaine.
129 r. Dihydroetorphine.
130 2. Any salt, compound, derivative, or preparation of a
131substance which is chemically equivalent to or identical with
132any of the substances referred to in subparagraph 1., except
133that these substances shall not include the isoquinoline
134alkaloids of opium.
135 3. Any part of the plant of the species Papaver
136somniferum, L.
137 4. Cocaine or ecgonine, including any of their
138stereoisomers, and any salt, compound, derivative, or
139preparation of cocaine or ecgonine.
140 (b) Unless specifically excepted or unless listed in
141another schedule, any of the following substances, including
142their isomers, esters, ethers, salts, and salts of isomers,
143esters, and ethers, whenever the existence of such isomers,
144esters, ethers, and salts is possible within the specific
145chemical designation:
146 1. Alfentanil.
147 2. Alphaprodine.
148 3. Anileridine.
149 4. Bezitramide.
150 5. Bulk propoxyphene (nondosage forms).
151 6. Carfentanil.
152 7. Dihydrocodeine.
153 8. Diphenoxylate.
154 9. Fentanyl.
155 10. Isomethadone.
156 11. Levomethorphan.
157 12. Levorphanol.
158 13. Metazocine.
159 14. Methadone.
160 15. Methadone-Intermediate,4-cyano-2-
161dimethylamino-4,4-diphenylbutane.
162 16. Moramide-Intermediate,2-methyl-
1633-morpholoino-1,1-diphenylpropane-carboxylic acid.
164 17. Nabilone.
165 18. Pethidine (meperidine).
166 19. Pethidine-Intermediate-A,4-cyano-1-
167methyl-4-phenylpiperidine.
168 20. Pethidine-Intermediate-B,ethyl-4-
169phenylpiperidine-4-carboxylate.
170 21. Pethidine-Intermediate-C,1-methyl-4- phenylpiperidine-
1714-carboxylic acid.
172 22. Phenazocine.
173 23. Phencyclidine.
174 24. 1-Phenylcyclohexylamine.
175 25. Piminodine.
176 26. 1-Piperidinocyclohexanecarbonitrile.
177 27. Racemethorphan.
178 28. Racemorphan.
179 29. Sufentanil.
180 30. Lisdexamfetamine.
181 31. Remifentanil.
182 (3) SCHEDULE III.-A substance in Schedule III has a
183potential for abuse less than the substances contained in
184Schedules I and II and has a currently accepted medical use in
185treatment in the United States, and abuse of the substance may
186lead to moderate or low physical dependence or high
187psychological dependence or, in the case of anabolic steroids,
188may lead to physical damage. The following substances are
189controlled in Schedule III:
190 (a) Unless specifically excepted or unless listed in
191another schedule, any material, compound, mixture, or
192preparation which contains any quantity of the following
193substances having a depressant or stimulant effect on the
194nervous system, including its salts, isomers, and salts of
195isomers whenever the existence of such salts, isomers, or salts
196of isomers is possible within the specific chemical designation:
197 1. Any substance which contains any quantity of a
198derivative of barbituric acid, including thiobarbituric acid, or
199any salt of a derivative of barbituric acid or thiobarbituric
200acid, including, but not limited to, butabarbital and
201butalbital.
202 2. Benzphetamine.
203 3. Chlorhexadol.
204 4. Chlorphentermine.
205 5. Clortermine.
206 6. Lysergic acid.
207 7. Lysergic acid amide.
208 8. Methyprylon.
209 9. Phendimetrazine.
210 10. Sulfondiethylmethane.
211 11. Sulfonethylmethane.
212 12. Sulfonmethane.
213 13. Tiletamine and zolazepam or any salt thereof.
214 14. Embutramide.
215 (4) SCHEDULE IV.-A substance in Schedule IV has a low
216potential for abuse relative to the substances in Schedule III
217and has a currently accepted medical use in treatment in the
218United States, and abuse of the substance may lead to limited
219physical or psychological dependence relative to the substances
220in Schedule III. Unless specifically excepted or unless listed
221in another schedule, any material, compound, mixture, or
222preparation which contains any quantity of the following
223substances, including its salts, isomers, and salts of isomers
224whenever the existence of such salts, isomers, and salts of
225isomers is possible within the specific chemical designation,
226are controlled in Schedule IV:
227 (a) Alprazolam.
228 (b) Barbital.
229 (c) Bromazepam.
230 (d) Camazepam.
231 (e) Cathine.
232 (f) Chloral betaine.
233 (g) Chloral hydrate.
234 (h) Chlordiazepoxide.
235 (i) Clobazam.
236 (j) Clonazepam.
237 (k) Clorazepate.
238 (l) Clotiazepam.
239 (m) Cloxazolam.
240 (n) Delorazepam.
241 (o) Propoxyphene (dosage forms).
242 (p) Diazepam.
243 (q) Diethylpropion.
244 (r) Estazolam.
245 (s) Ethchlorvynol.
246 (t) Ethinamate.
247 (u) Ethyl loflazepate.
248 (v) Fencamfamin.
249 (w) Fenfluramine.
250 (x) Fenproporex.
251 (y) Fludiazepam.
252 (z) Flurazepam.
253 (aa) Halazepam.
254 (bb) Haloxazolam.
255 (cc) Ketazolam.
256 (dd) Loprazolam.
257 (ee) Lorazepam.
258 (ff) Lormetazepam.
259 (gg) Mazindol.
260 (hh) Mebutamate.
261 (ii) Medazepam.
262 (jj) Mefenorex.
263 (kk) Meprobamate.
264 (ll) Methohexital.
265 (mm) Methylphenobarbital.
266 (nn) Midazolam.
267 (oo) Nimetazepam.
268 (pp) Nitrazepam.
269 (qq) Nordiazepam.
270 (rr) Oxazepam.
271 (ss) Oxazolam.
272 (tt) Paraldehyde.
273 (uu) Pemoline.
274 (vv) Pentazocine.
275 (ww) Phenobarbital.
276 (xx) Phentermine.
277 (yy) Pinazepam.
278 (zz) Pipradrol.
279 (aaa) Prazepam.
280 (bbb) Propylhexedrine, excluding any patent or proprietary
281preparation containing propylhexedrine, unless otherwise
282provided by federal law.
283 (ccc) Quazepam.
284 (ddd) Tetrazepam.
285 (eee) SPA[(-)-1 dimethylamino-1, 2 diphenylethane].
286 (fff) Temazepam.
287 (ggg) Triazolam.
288 (hhh) Not more than 1 milligram of difenoxin and not less
289than 25 micrograms of atropine sulfate per dosage unit.
290 (iii) Butorphanol tartrate.
291 (jjj) Carisoprodol.
292 (kkk) Zopiclone.
293 (lll) Zaleplon.
294 (mmm) Zolpidem.
295 (nnn) Modafinil.
296 (ooo) Petrichloral.
297 (ppp) Sibutramine.
298 (qqq) Dichloralphenazone.
299 (5) SCHEDULE V.-A substance, compound, mixture, or
300preparation of a substance in Schedule V has a low potential for
301abuse relative to the substances in Schedule IV and has a
302currently accepted medical use in treatment in the United
303States, and abuse of such compound, mixture, or preparation may
304lead to limited physical or psychological dependence relative to
305the substances in Schedule IV.
306 (b) Narcotic drugs. Unless specifically excepted or unless
307listed in another schedule, any material, compound, mixture, or
308preparation containing any of the following narcotic drugs and
309their salts:
310 1. Buprenorphine.
311 2. Pregabalin.
312 3. Not more than 0.5 milligrams of difenoxin and not less
313than 25 micrograms of atrophine sulfate per dosage unit.
314 Section 2. This act shall take effect July 1, 2010.
CODING: Words stricken are deletions; words underlined are additions.
feedback